Anti-LTA4H monoclonal antibody

Pre-made anti-LTA4H monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LTA4H/LTA4H products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T03691-Ab-1/ GM-Tg-hg-T03691-Ab-2Anti-Human LTA4H monoclonal antibodyHuman
GM-Tg-rg-T03691-Ab-1/ GM-Tg-rg-T03691-Ab-2Anti-Rat LTA4H monoclonal antibodyRat
GM-Tg-mg-T03691-Ab-1/ GM-Tg-mg-T03691-Ab-2Anti-Mouse LTA4H monoclonal antibodyMouse
GM-Tg-cynog-T03691-Ab-1/ GM-Tg-cynog-T03691-Ab-2Anti-Cynomolgus/ Rhesus macaque LTA4H monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T03691-Ab-1/ GM-Tg-felg-T03691-Ab-2Anti-Feline LTA4H monoclonal antibodyFeline
GM-Tg-cang-T03691-Ab-1/ GM-Tg-cang-T03691-Ab-2Anti-Canine LTA4H monoclonal antibodyCanine
GM-Tg-bovg-T03691-Ab-1/ GM-Tg-bovg-T03691-Ab-2Anti-Bovine LTA4H monoclonal antibodyBovine
GM-Tg-equg-T03691-Ab-1/ GM-Tg-equg-T03691-Ab-2Anti-Equine LTA4H monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T03691-Ab-1/ GM-Tg-hg-T03691-Ab-2; GM-Tg-rg-T03691-Ab-1/ GM-Tg-rg-T03691-Ab-2;
GM-Tg-mg-T03691-Ab-1/ GM-Tg-mg-T03691-Ab-2; GM-Tg-cynog-T03691-Ab-1/ GM-Tg-cynog-T03691-Ab-2;
GM-Tg-felg-T03691-Ab-1/ GM-Tg-felg-T03691-Ab-2; GM-Tg-cang-T03691-Ab-1/ GM-Tg-cang-T03691-Ab-2;
GM-Tg-bovg-T03691-Ab-1/ GM-Tg-bovg-T03691-Ab-2; GM-Tg-equg-T03691-Ab-1/ GM-Tg-equg-T03691-Ab-2
Products NameAnti-LTA4H monoclonal antibody
Formatmab
Target NameLTA4H
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LTA4H monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T03691-Ag-1Recombinant multi-species LKHA4/ LTA4H protein
    ORF Viral VectorpGMLPm003430mouse Lta4h Lentivirus plasmid
    ORF Viral VectorvGMLPm003430mouse Lta4h Lentivirus particle


    Target information

    Target IDGM-T03691
    Target NameLTA4H
    Gene ID4048,16993,299732,713038,482611,101083948,507130,100052257
    Gene Symbol and SynonymsLTA4H
    Uniprot AccessionP09960,P30349,Q3SZH7
    Uniprot Entry NameLKHA4_HUMAN,LKHA4_RAT,LKHA4_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000111144
    Target ClassificationN/A

    The target: LTA4H, gene name: LTA4H, also named as . The protein encoded by this gene is an enzyme that contains both hydrolase and aminopeptidase activities. The hydrolase activity is used in the final step of the biosynthesis of leukotriene B4, a proinflammatory mediator. The aminopeptidase activity has been shown to degrade proline-glycine-proline (PGP), a neutrophil chemoattractant and biomarker for chronic obstructive pulmonary disease (COPD). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.